Myocarditis in Patients Starting Combination Checkpoint Inhibitor Therapy: Analysis of a Commercial Claims Database

Background Immune checkpoint inhibitors have improved the clinical outcomes of several cancers but have also been associated with a greater risk of immune‐related adverse effects, especially when combined. The objective of this study was to investigate the incidence of myocarditis in relation to the...

Full description

Bibliographic Details
Main Authors: Alistair C. Lindsay, Alexander M. Walker, Sebastian Schneeweiss
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.035689